Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma.

PubWeight™: 1.83‹?› | Rank: Top 3%

🔗 View Article (PMID 15534120)

Published in Clin Cancer Res on November 01, 2004

Authors

Thomas Armstrong1, Graham Packham, Lindsay B Murphy, Adrian C Bateman, John A Conti, David R Fine, Colin D Johnson, R Christopher Benyon, John P Iredale

Author Affiliations

1: Divisions of Tissue Remodelling and Repair, University of Southampton, Southampton General Hospital, Southampton, United Kingdom. armstrongthomas@talk21.com

Articles citing this

Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell (2014) 5.87

The pancreatic stellate cell: a star on the rise in pancreatic diseases. J Clin Invest (2007) 3.39

KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma. Nat Rev Cancer (2010) 3.27

Dynamic interplay between the collagen scaffold and tumor evolution. Curr Opin Cell Biol (2010) 2.79

Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice. J Clin Invest (2009) 2.66

RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma. Cell (2015) 1.80

Collagen I-mediated up-regulation of N-cadherin requires cooperative signals from integrins and discoidin domain receptor 1. J Cell Biol (2008) 1.66

CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis. Fibrogenesis Tissue Repair (2012) 1.49

Pancreatic stellate cells radioprotect pancreatic cancer cells through β1-integrin signaling. Cancer Res (2011) 1.46

Three-dimensional collagen I promotes gemcitabine resistance in pancreatic cancer through MT1-MMP-mediated expression of HMGA2. Cancer Res (2010) 1.38

Desmoplasia of pancreatic ductal adenocarcinoma. Clin Gastroenterol Hepatol (2009) 1.33

Integrin signaling in cancer cell survival and chemoresistance. Chemother Res Pract (2012) 1.26

FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells. BMC Cancer (2011) 1.24

Knockdown of the β(1) integrin subunit reduces primary tumor growth and inhibits pancreatic cancer metastasis. Int J Cancer (2011) 1.22

The alpha2beta1 integrin mediates the malignant phenotype on type I collagen in pancreatic cancer cell lines. Br J Cancer (2006) 1.19

Intrinsic chemoresistance to gemcitabine is associated with constitutive and laminin-induced phosphorylation of FAK in pancreatic cancer cell lines. Mol Cancer (2009) 1.18

Constitutive non-canonical NFkappaB signaling in pancreatic cancer cells. Cancer Biol Ther (2009) 1.17

Molecular mechanism of pancreatic cancer--understanding proliferation, invasion, and metastasis. Langenbecks Arch Surg (2010) 1.10

Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance. World J Gastroenterol (2012) 1.08

The desmoplastic reaction surrounding hepatic colorectal adenocarcinoma metastases aids tumor growth and survival via alphav integrin ligation. Clin Cancer Res (2008) 1.08

Novel curcumin-loaded magnetic nanoparticles for pancreatic cancer treatment. Mol Cancer Ther (2013) 1.01

Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome. Proc Natl Acad Sci U S A (2012) 1.00

Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment. Curr Pharm Des (2012) 0.98

Desmoplasia and chemoresistance in pancreatic cancer. Cancers (Basel) (2014) 0.93

Type IV collagen stimulates pancreatic cancer cell proliferation, migration, and inhibits apoptosis through an autocrine loop. BMC Cancer (2013) 0.92

Integrin-mediated laminin-1 adhesion upregulates CXCR4 and IL-8 expression in pancreatic cancer cells. Surgery (2007) 0.92

Pathophysiological role of microRNA-29 in pancreatic cancer stroma. Sci Rep (2015) 0.92

Periductal stromal collagen topology of pancreatic ductal adenocarcinoma differs from that of normal and chronic pancreatitis. Mod Pathol (2015) 0.91

Analysis of the intra- and intertumoral heterogeneity of hypoxia in pancreatic cancer patients receiving the nitroimidazole tracer pimonidazole. Br J Cancer (2015) 0.88

Pancreatic cancer cells enhance the ability of collagen internalization during epithelial-mesenchymal transition. PLoS One (2012) 0.88

Synergistic growth inhibitory effects of the dual endothelin-1 receptor antagonist bosentan on pancreatic stellate and cancer cells. Dig Dis Sci (2008) 0.86

Pancreatic stellate cells: new kids become mature. Gut (2006) 0.85

Therapeutic potential of perineural invasion, hypoxia and desmoplasia in pancreatic cancer. Curr Pharm Des (2012) 0.84

Decreased decorin expression in the tumor microenvironment. Cancer Med (2014) 0.83

Novel patient-derived xenograft mouse model for pancreatic acinar cell carcinoma demonstrates single agent activity of oxaliplatin. J Transl Med (2016) 0.82

A bioengineered heterotypic stroma-cancer microenvironment model to study pancreatic ductal adenocarcinoma. Lab Chip (2013) 0.82

Pancreatic cancer cell glycosylation regulates cell adhesion and invasion through the modulation of α2β1 integrin and E-cadherin function. PLoS One (2014) 0.82

Alphav integrins lead the way for colorectal metastases. Clin Cancer Res (2008) 0.82

Involvement of host stroma cells and tissue fibrosis in pancreatic tumor development in transgenic mice. PLoS One (2012) 0.81

Adipose tissue-derived stem cells promote pancreatic cancer cell proliferation and invasion. Braz J Med Biol Res (2013) 0.81

Distinct antifibrogenic effects of erlotinib, sunitinib and sorafenib on rat pancreatic stellate cells. World J Gastroenterol (2014) 0.81

Nanoparticle amplification via photothermal unveiling of cryptic collagen binding sites. J Mater Chem B Mater Biol Med (2013) 0.79

CD271⁺ subpopulation of pancreatic stellate cells correlates with prognosis of pancreatic cancer and is regulated by interaction with cancer cells. PLoS One (2012) 0.79

Bone marrow mesenchymal stem cells promote osteosarcoma cell proliferation and invasion. World J Surg Oncol (2015) 0.78

Germ line polymorphisms as predictive markers for pre-surgical radiochemotherapy in locally advanced rectal cancer: a 5-year literature update and critical review. Eur J Clin Pharmacol (2015) 0.78

CD90 and CD24 Co-Expression Is Associated with Pancreatic Intraepithelial Neoplasias. PLoS One (2016) 0.77

Targeting reactive oxygen species in development and progression of pancreatic cancer. Expert Rev Anticancer Ther (2016) 0.77

Fibroblast-Mediated Collagen Remodeling Within the Tumor Microenvironment Facilitates Progression of Thyroid Cancers Driven by BrafV600E and Pten Loss. Cancer Res (2016) 0.76

Divalent cations modulate alpha2beta1 integrin-mediated malignancy in a novel 3-dimensional in vitro model of pancreatic cancer. Pancreas (2010) 0.76

Angiogenesis in pancreatic ductal adenocarcinoma: A controversial issue. Oncotarget (2016) 0.76

Matrix stiffness induces epithelial-mesenchymal transition and promotes chemoresistance in pancreatic cancer cells. Oncogenesis (2017) 0.76

CASTIN: a system for comprehensive analysis of cancer-stromal interactome. BMC Genomics (2016) 0.75

Highly aligned stromal collagen is a negative prognostic factor following pancreatic ductal adenocarcinoma resection. Oncotarget (2016) 0.75

Characterization and use of HapT1-derived homologous tumors as a preclinical model to evaluate therapeutic efficacy of drugs against pancreatic tumor desmoplasia. Oncotarget (2016) 0.75

ECM Composition and Rheology Regulate Growth, Motility and Response to Photodynamic Therapy in 3D Models of Pancreatic Ductal Adenocarcinoma. Mol Cancer Res (2016) 0.75

Stromal SPOCK1 supports invasive pancreatic cancer growth. Mol Oncol (2017) 0.75

Molecular MR imaging of fibrosis in a mouse model of pancreatic cancer. Sci Rep (2017) 0.75

THE FIFTH SENSE: MECHANOSENSORY REGULATION OF ALPHA-ACTININ-4 AND ITS RELEVANCE FOR CANCER METASTASIS. Semin Cell Dev Biol (2017) 0.75

The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma. PLoS One (2017) 0.75

The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer. Int J Mol Sci (2017) 0.75

Articles by these authors

Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut (2012) 10.56

Consensus statement on the pathology of IgG4-related disease. Mod Pathol (2012) 9.01

Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest (2005) 8.58

Assessment of the economic impact of porcine reproductive and respiratory syndrome on swine production in the United States. J Am Vet Med Assoc (2005) 4.81

Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nat Med (2012) 3.96

Generation of functional human hepatic endoderm from human induced pluripotent stem cells. Hepatology (2010) 3.36

Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nat Med (2013) 3.35

Maternal high-fat feeding primes steatohepatitis in adult mice offspring, involving mitochondrial dysfunction and altered lipogenesis gene expression. Hepatology (2009) 3.11

Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling. Proc Natl Acad Sci U S A (2008) 2.99

Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis. J Biol Chem (2002) 2.88

Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. Am J Pathol (2008) 2.83

Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc Natl Acad Sci U S A (2006) 2.75

Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J Immunol (2007) 2.64

Early antibiotic treatment for severe acute necrotizing pancreatitis: a randomized, double-blind, placebo-controlled study. Ann Surg (2007) 2.55

Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proc Natl Acad Sci U S A (2012) 2.54

The bone marrow functionally contributes to liver fibrosis. Gastroenterology (2006) 2.52

Elastin accumulation is regulated at the level of degradation by macrophage metalloelastase (MMP-12) during experimental liver fibrosis. Hepatology (2012) 2.52

Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking. Gastroenterology (2004) 2.44

Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function. Hepatology (2011) 2.27

Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis. Am J Respir Crit Care Med (2011) 2.15

B-cell receptor signaling in chronic lymphocytic leukemia. Blood (2011) 2.11

Branched chain in situ hybridization for albumin as a marker of hepatocellular differentiation: evaluation of manual and automated in situ hybridization platforms. Am J Surg Pathol (2015) 2.02

Mcl-1. Int J Biochem Cell Biol (2005) 1.96

Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia. Blood (2002) 1.85

Liver fibrosis: cellular mechanisms of progression and resolution. Clin Sci (Lond) (2007) 1.77

Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis. Gastroenterology (2005) 1.73

Expression of matrix metalloproteinase-2 and -14 persists during early resolution of experimental liver fibrosis and might contribute to fibrolysis. Liver Int (2004) 1.69

Targeting B-cell anergy in chronic lymphocytic leukemia. Blood (2013) 1.66

Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells. Hepatology (2011) 1.65

Vascular invasion is underrecognized in colorectal cancer using conventional hematoxylin and eosin staining. Dis Colon Rectum (2007) 1.64

Unbiased screening of polymer libraries to define novel substrates for functional hepatocytes with inducible drug metabolism. Stem Cell Res (2010) 1.62

Engagement of alphavbeta3 integrin regulates proliferation and apoptosis of hepatic stellate cells. J Biol Chem (2004) 1.59

Modeling liver fibrosis in rodents. Methods Mol Med (2005) 1.57

Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status. Blood (2007) 1.55

Mcl-1 is required for Akata6 B-lymphoma cell survival and is converted to a cell death molecule by efficient caspase-mediated cleavage. Oncogene (2004) 1.53

Nuclear factor-kappaB1 (p50) limits the inflammatory and fibrogenic responses to chronic injury. Am J Pathol (2005) 1.53

Relaxin modulates human and rat hepatic myofibroblast function and ameliorates portal hypertension in vivo. Hepatology (2014) 1.52

Hepatic changes in the failing Fontan circulation. Heart (2006) 1.48

Stimulating healthy tissue regeneration by targeting the 5-HT₂B receptor in chronic liver disease. Nat Med (2011) 1.45

Characterisation of a stereotypical cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver. Gut (2010) 1.44

Carboxypeptidase-B activation peptide, a marker of pancreatic acinar injury, but not L-selectin, a marker of neutrophil activation, predicts severity of acute pancreatitis. J Gastroenterol Hepatol (2007) 1.43

Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26. Am J Gastroenterol (2005) 1.43

The NF-kappaB p50:p50:HDAC-1 repressor complex orchestrates transcriptional inhibition of multiple pro-inflammatory genes. J Hepatol (2010) 1.37

S-adenosylhomocysteine hydrolase inhibition by 3-deazaneplanocin A analogues induces anti-cancer effects in breast cancer cell lines and synergy with both histone deacetylase and HER2 inhibition. Breast Cancer Res Treat (2010) 1.36

Significant differences in nucleocapsid morphology within the Paramyxoviridae. J Gen Virol (2002) 1.33

Progress and future challenges in stem cell-derived liver technologies. Am J Physiol Gastrointest Liver Physiol (2009) 1.32

Basement membrane-like matrix inhibits proliferation and collagen synthesis by activated rat hepatic stellate cells: evidence for matrix-dependent deactivation of stellate cells. Matrix Biol (2003) 1.32

How can transforming growth factor beta be targeted usefully to combat liver fibrosis? Eur J Gastroenterol Hepatol (2004) 1.30

miR-153 supports colorectal cancer progression via pleiotropic effects that enhance invasion and chemotherapeutic resistance. Cancer Res (2013) 1.29

Regulation of hepatic stellate cell proliferation and collagen synthesis by proteinase-activated receptors. J Hepatol (2002) 1.28

Developing high-fidelity hepatotoxicity models from pluripotent stem cells. Stem Cells Transl Med (2013) 1.27

BAG-1: a multifunctional regulator of cell growth and survival. Biochim Biophys Acta (2003) 1.26

Bone marrow injection stimulates hepatic ductular reactions in the absence of injury via macrophage-mediated TWEAK signaling. Proc Natl Acad Sci U S A (2013) 1.20

Reversal of fibrosis: no longer a pipe dream? Clin Liver Dis (2006) 1.18

Persistence of functional hepatocyte-like cells in immune-compromised mice. Liver Int (2010) 1.18

Stereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: a pilot trial demonstrating safety. Radiat Oncol (2013) 1.18

Reversibility of liver fibrosis. Ann Hepatol (2009) 1.16

The normal IGHV1-69-derived B-cell repertoire contains stereotypic patterns characteristic of unmutated CLL. Blood (2009) 1.15

BAG-1: a multi-functional pro-survival molecule. Int J Biochem Cell Biol (2005) 1.14

Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins. Proc Natl Acad Sci U S A (2010) 1.14

Laparoscopic versus open distal pancreatectomy: a clinical and cost-effectiveness study. Surg Endosc (2011) 1.11

CINC-1 is an acute-phase protein induced by focal brain injury causing leukocyte mobilization and liver injury. FASEB J (2003) 1.11

Surface IgM stimulation induces MEK1/2-dependent MYC expression in chronic lymphocytic leukemia cells. Blood (2011) 1.11

Total synthesis of spiruchostatin A, a potent histone deacetylase inhibitor. J Am Chem Soc (2004) 1.11

Mechanisms and clinical significance of BIM phosphorylation in chronic lymphocytic leukemia. Blood (2011) 1.09

The first biologically active synthetic analogues of FK228, the depsipeptide histone deacetylase inhibitor. J Med Chem (2007) 1.09

The inhibitory role of stromal cell mesenchyme on human embryonic stem cell hepatocyte differentiation is overcome by Wnt3a treatment. Cloning Stem Cells (2008) 1.09

The comparison between conditioned media and serum-free media in human embryonic stem cell culture and differentiation. Cell Reprogram (2010) 1.08

The desmoplastic reaction surrounding hepatic colorectal adenocarcinoma metastases aids tumor growth and survival via alphav integrin ligation. Clin Cancer Res (2008) 1.08

Accurate prediction of drug-induced liver injury using stem cell-derived populations. Stem Cells Transl Med (2013) 1.07

Identification in CLL of circulating intraclonal subgroups with varying B-cell receptor expression and function. Blood (2013) 1.05

Remodelling of extracellular matrix is a requirement for the hepatic progenitor cell response. Gut (2010) 1.05

The nuclear BAG-1 isoform, BAG-1L, enhances oestrogen-dependent transcription. Oncogene (2003) 1.04

Emerging therapies for liver fibrosis. Dig Dis (2006) 1.04

Macrophages: central regulators of hepatic fibrogenesis and fibrosis resolution. J Hepatol (2012) 1.04

p75 Neurotrophin receptor signaling regulates hepatic myofibroblast proliferation and apoptosis in recovery from rodent liver fibrosis. Hepatology (2009) 1.04

Expression of CtBP family protein isoforms in breast cancer and their role in chemoresistance. Biol Cell (2010) 1.03

Colonic expression of leukotriene-pathway enzymes in inflammatory bowel diseases. Inflamm Bowel Dis (2007) 1.03

The epidemiology and socioeconomic impact of chronic pancreatitis. Best Pract Res Clin Gastroenterol (2010) 1.03

Hepatocytes express nerve growth factor during liver injury: evidence for paracrine regulation of hepatic stellate cell apoptosis. Am J Pathol (2003) 1.02

BAG-1 prevents stress-induced long-term growth inhibition in breast cancer cells via a chaperone-dependent pathway. Cancer Res (2003) 1.01

SUMOylation of HNF4α regulates protein stability and hepatocyte function. J Cell Sci (2012) 1.01

Impaired proteolysis of collagen I inhibits proliferation of hepatic stellate cells: implications for regulation of liver fibrosis. J Biol Chem (2006) 1.00

Inhibition of hypoxia inducible factor by phenethyl isothiocyanate. Biochem Pharmacol (2009) 1.00

Increased angiogenesis protects against adipose hypoxia and fibrosis in metabolic disease-resistant 11β-hydroxysteroid dehydrogenase type 1 (HSD1)-deficient mice. J Biol Chem (2011) 0.99

The NF-κB subunit c-Rel stimulates cardiac hypertrophy and fibrosis. Am J Pathol (2011) 0.98

Enantioselective synthesis of tranylcypromine analogues as lysine demethylase (LSD1) inhibitors. Bioorg Med Chem (2011) 0.97